Compounded Tirzepatide Dosage in Units: Why There Is No Single Answer

If you have moved from a Zepbound or Mounjaro pen to a compounded tirzepatide vial, you have run into a question the pen never asked you: how many units do I draw? The honest answer is that the question, as usually asked, has no single correct number. A “unit” on a U-100 insulin syringe is a measure of volume — one unit is 0.01 mL — and it says nothing about how much tirzepatide is dissolved in that volume. The same 20 units can be 2 mg from one vial and 4 mg from another. Getting this wrong is not a rounding error: a case series from a poison control center documents patients who drew up their intended number in the wrong scale and received five to twenty times their prescribed dose^[1].

Why the pen never made you do this

Brand-name tirzepatide pens are dose-marked. A Zepbound single-dose pen delivers one fixed dose and there is nothing to measure — you do not select a volume, and the concept of “units” never appears. Compounded tirzepatide is usually supplied as a multi-dose vial instead, and the syringe most commonly sold alongside it is an insulin syringe, because it is the cheap, widely available syringe in the right volume range. That syringe is calibrated for insulin, a drug that is standardized at 100 units per mL. Tirzepatide has no “unit” — it is dosed in milligrams — so the markings you are reading were designed for a different drug entirely.

This is the whole source of the confusion. The syringe is telling you a volume. Your prescription is written in milligrams. The vial's concentration is the only thing that connects the two, and it varies between pharmacies and between batches.

The arithmetic, in one line

Worked once: a 2.5 mg dose from a vial concentrated at 10 mg/mL needs 2.5 ÷ 10 = 0.25 mL, and 0.25 × 100 = 25 units. The identical 2.5 mg dose from a 20 mg/mL vial needs 2.5 ÷ 20 = 0.125 mL, which is 12.5 units — half as far up the barrel, for exactly the same amount of drug.

Two things are worth noticing in that table. First, the same row spans a fourfold range depending only on concentration — which is why “how many units is 5 mg of tirzepatide” cannot be answered by a stranger. Second, several cells exceed the capacity of a standard 1 mL insulin syringe, so a dose that needs 150 units is not one syringe-full; anyone telling you to draw “150 units” from a 1 mL barrel is describing something physically impossible in one draw.

Reading it backwards: what a given number of units contains

The reverse question — “how many mg is 20 units of tirzepatide?” — has the same dependency, and the same answer shape: mg = (units ÷ 100) × concentration. Twenty units is 0.2 mL. From a 10 mg/mL vial that is 2 mg; from a 20 mg/mL vial it is 4 mg. Neither number is more correct than the other; they describe two different vials.

What goes wrong, documented

This is not a theoretical hazard. A case series published in the Journal of the American Pharmacists Association described patients who contacted a poison control center after administration errors with compounded semaglutide — the same vial-and-insulin-syringe setup, the same scale confusion^[1]. The recurring pattern was a patient instructed in one scale and measuring in another, producing doses far above what was intended, with nausea and vomiting severe enough to prompt the call.

The pharmacology makes an overdose particularly unforgiving. Tirzepatide is cleared slowly: population pharmacokinetic modeling puts its half-life in the range that supports once-weekly dosing^[3], and human ADME work confirms it is eliminated over days rather than hours^[4]. There is no way to undo a tenfold draw by waiting a few hours — the exposure is already committed, and the gastrointestinal effects follow the drug's own timeline.

The smaller error nobody mentions: dead space

Every syringe retains a little fluid in the hub and needle after the plunger bottoms out. That residual volume is called dead space, and it was described as a dosing hazard in the insulin literature decades ago^[2]. It matters more the smaller your draw: losing a few hundredths of a milliliter out of a 100-unit draw is trivial, but the same loss out of a 12.5-unit draw is a meaningful fraction of the dose. Low-dead-space syringes exist and reduce it. This is a reason to prefer a syringe sized close to your actual draw volume rather than a much larger one — and a reason not to assume a “short” draw at a high concentration is the more accurate option just because the number is smaller.

Practical rules that follow from the arithmetic

• Find the concentration before anything else. It is expressed as mg/mL. If the vial states only a total quantity, for example “20 mg”, that is not a concentration until you also know the volume it is dissolved in.
• Write the dose in milligrams, not units, when you talk to anyone. Milligrams travel between pharmacies and clinicians correctly; units do not, because they carry a hidden assumption about concentration.
• Re-do the arithmetic every time the vial changes. A new pharmacy, a new batch, or a switch in concentration invalidates the number you have been using, even at the same prescribed dose. This is the single most common way a stable patient's dose silently changes.
• Check the syringe scale, not just the number. U-100 is the assumption behind the ×100 multiplier. A U-40 syringe or one marked in milliliters will give a different answer from the same barrel position.
• If the two numbers disagree, stop. If your prescribed milligrams and the units you have been told to draw do not reconcile through the formula, the discrepancy is the finding. Call the pharmacy rather than splitting the difference.